Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cellular reprogramming by protein degradation: The next frontier in cancer immunotherapy

Cell chemical biology(2024)10.1016/j.chembiol.2024.01.004Source: DataRank Database

Cellular reprogramming by protein degradation: The next frontier in cancer immunotherapy is a research paper published in Cell chemical biology (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.00)OA: greenTopics (35)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Anjana Rao ORCID,Erik Ehinger ORCID

Live enrichment

PubMed:38364775 PMC:PMC11951944 OpenAlex:https://openalex.org/W4391850813

NIDCR NIH HHS

Grant: U01 DE028227

NIAID NIH HHS

Grant: R01 AI040127

FWCI

0.00

Citation Percentile

0.0%

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11951944/pdf/nihms-2063913.pdf

publisherhttps://api.elsevier.com/content/article/PII:S2451945624000400?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2451945624000400?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11951944

Fields of Study

Protein Degradation and InhibitorsUbiquitin and proteasome pathwaysCAR-T cell therapy researchHumansProteolysisSignal TransductionUbiquitin-Protein LigasesNeoplasmsImmunotherapyCellular Reprogramming

MeSH Terms

HumansImmunotherapyNeoplasmsSignal TransductionUbiquitin-Protein LigasesProteolysisCellular Reprogramming

Keywords

ReprogrammingImmunotherapyBiologyFusion proteinCell biologySMADTranscription factorMechanism (biology)Computational biologyCancer immunotherapyTransgeneCancer researchCancerCellSignal transductionGeneticsRecombinant DNAGene

Sustainable Development Goals

SDG 0: Good health and well-being